Ozempic® is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes and to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes mellitus and established CV disease. Body weight reduction was a secondary endpoint in clinical trials.
Ozempic (active ingredient, Semaglutide) is an injectable prescription medicine used alongside a healthy diet and exercise to improve blood sugar levels and lower A1C in adults with type 2 diabetes. Ozempic reduces the risk of major cardiovascular problems such as heart attack, stroke and even death in adults known to have heart disease.
Ozempic acts in a similar way to a hormone that already occurs in our bodies and helps to regulate our blood sugar, insulin levels and our digestion.
Ozempic is a pre-filled, disposable, single-patient-use injection pen which is taken once a week. It’s usually administered to patients after an unsuccessful course of other diabetes medicine.
Ozempic is not suitable for adults with Type 1 Diabetes. It is still unknown whether or not it is suitable for children under the age of 18.
Reviews
There are no reviews yet.